GLP-1 Drugs Use, Risks, and Regulation

• GLP-1 receptor agonists (GLP-1 RAs) are a class of injectable/oral drugs that mimic the gut hormone glucagon-like peptide-1, lowering blood sugar and inducing weight loss; originally licensed for Type 2 Diabetes Mellitus (T2DM), now widely used off-label and on-label for obesity.
• Examinable as a Science & Tech / Health Governance issue: intersects CDSCO drug regulation, NCD burden, WHO Essential Medicines List, and pharma IPR (semaglutide patent expiry 2026 in India).